Browse by Title

Type here to filter the list

S
(Scientific Abstract Presentation) A prospective, real-world evidence study evaluating the effect of topical diclofenac (Voltaren gel) on functional mobility and quality of life in adults with osteoarthritis of the knee (SAP-04)
Sponsored By
Favorite

Karin Nicholson, PhD, BCMAS – Haleon ### 2099292###Poster Presenter###Principal Scientist Medical & Scientific Affairs###Haleon###
Poster Presenter: Karin Nicholson, PhD, BCMAS – Haleon
### SAP-04
(Scientific Abstract Presentation) Efficacy and safety of MR-107A-02 (novel fast-acting meloxicam formulation) for the treatment of acute moderate-to-severe pain following bunionectomy (SAP-06)
Sponsored By
Favorited

Jessica C. McCoun, MD – CenExel ACMR Atlanta ### 2750007###Poster Presenter###Principal Investigator###CenExel ACMR Atlanta###
Poster Presenter: Jessica C. McCoun, MD – CenExel ACMR Atlanta
### SAP-06
(Scientific Abstract Presentation) Efficacy and safety of MR-107A-02 (novel meloxicam fast-acting formulation) for the treatment of acute moderate-to-severe pain following herniorrhaphy (SAP-07)
Sponsored By
Favorited

Jessica C. McCoun, MD – CenExel ACMR Atlanta ### 2750007###Poster Presenter###Principal Investigator###CenExel ACMR Atlanta###
Poster Presenter: Jessica C. McCoun, MD – CenExel ACMR Atlanta
### SAP-07
(Scientific Abstract Presentation) No Pill Security In The Home (SAP-02)
Sponsored By iPill
Favorited

John Hsu, MD – iPill inc ### 2769329###Poster Presenter###CEO###iPill inc###
Poster Presenter: John Hsu, MD – iPill inc
### SAP-02
(Scientific Abstract Presentation) Opioid sparing effect of MR-107A-02 (novel fast-acting meloxicam formulation) for the treatment of acute moderate-to-severe pain following bunionectomy and herniorrhaphy (SAP-08)
Sponsored By
Favorited

Susanne R. Vogt, n/a – Viatris ### 2759554###Poster Presenter###Senior Clinical Sciences Lead###Viatris###
Poster Presenter: Susanne R. Vogt, n/a – Viatris
### SAP-08
(Scientific Abstract Presentation) Pharmacokinetics study comparing MR-107A-02 (novel fast-acting meloxicam formulation) 15mg tablet with meloxicam (Mobic®) 15mg in healthy adult male subjects (SAP-05)
Sponsored By
Favorited

Matthew A. Hummel, Ph.D. – Viatris ### 2750006###Poster Presenter###Principal Research Scientist###Viatris###
Poster Presenter: Matthew A. Hummel, Ph.D. – Viatris
### SAP-05
(Scientific Abstract Presentation) Results of a Randomized, Placebo-Controlled, Phase 3 Trial of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty (SAP-03)
Sponsored By
Favorite

James Hackworth, PhD – Tris Pharma, Inc. ### 1764558###Poster Presenter###Chief Business Officer###Tris Pharma, Inc.###
Poster Presenter: James Hackworth, PhD – Tris Pharma, Inc.
### SAP-03
(Scientific Abstract Presentation) Should I test for Novel Psychoactive Substances (NPS) in Clinical Specimens? (SAP-01)
Favorited

Jillian Neifeld, MS, D-ABFT-FT – Quest Diagnostics ### 2759488###Poster Presenter###Staff Scientist, R&D Toxicology###Quest Diagnostics###
Poster Presenter: Jillian Neifeld, MS, D-ABFT-FT – Quest Diagnostics
### SAP-01
(Sponsored Breakfast Presentation) Optimizing Care in Fibromyalgia: Advancing Patient Outcomes from Diagnosis to Therapeutic Interventions (PDM-06)
Sponsored By:
Favorite

Steven P. Stanos, DO – Swedish Health System ### 1061506###Co-Presenter###Medical Director, Pain Medicine and Services###Swedish Health System###
Co-Presenter: Steven P. Stanos, DO – Swedish Health System
### @@@ Pamela Kushner, MD, FAAFP – University of California at Irvine ### 2780934###Co-Presenter###Clinical Professor of Family Medicine###University of California at Irvine###
Co-Presenter: Pamela Kushner, MD, FAAFP – University of California at Irvine
### PDM-06
(Sponsored Breakfast Presentation) Responsible Pain Management: Opioid Therapies for Patients with Severe and Persistent Pain (PDM-04)
Sponsored By
Favorite

Lynn R. Webster, MD (he/him/his) – Dr. Vince Clinical Research ### 1089075###Presenter###Executive Vice President Scientific Affairs###Dr. Vince Clinical Research###
Presenter: Lynn R. Webster, MD (he/him/his) – Dr. Vince Clinical Research
### he/him/his PDM-04
(Sponsored Breakfast Presentation) There's a Ton to be Excited About with the First FDA-Approved Treatment for Fibromyalgia in Over 15 Years (PDM-01)
Sponsored By
Favorite

Jeffrey Gudin, MD – Department of Anesthesiology, University of Miami, Miller School of Medicine, Miami, FL, USA ### 1076687###Co-Presenter###Professor###Department of Anesthesiology, University of Miami, Miller School of Medicine, Miami, FL, USA###
Co-Presenter: Jeffrey Gudin, MD – Department of Anesthesiology, University of Miami, Miller School of Medicine, Miami, FL, USA
### @@@ Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, FAANP – Stanford Health Care - Division Pain Medicine ### 1052752###Co-Presenter###Adult Nurse Practitioner###Stanford Health Care - Division Pain Medicine###
Co-Presenter: Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, FAANP – Stanford Health Care - Division Pain Medicine
### PDM-01
(Sponsored Dinner Presentation) Acute Pain Management: Early Clinical Experience with Suzetrigine (PDM-03)
Sponsored By
Favorite

Charles E. Argoff, MD – Albany Medical College/Albany Medical Center ### 1052705###Co-Presenter###Professor of Neurology and Director of Comprehensive Pain Program###Albany Medical College/Albany Medical Center###
Co-Presenter: Charles E. Argoff, MD – Albany Medical College/Albany Medical Center
### @@@ Michael M. Bottros, MD – Keck School of Medicine of USC ### 1052713###Co-Presenter###Clinical Operations and Medical Director for Pain Services, Department of Anesthesiology###Keck School of Medicine of USC###
Co-Presenter: Michael M. Bottros, MD – Keck School of Medicine of USC
### @@@ Jai Mehta, MD, MBA, FASA – Pain Program at Vertex Pharmaceuticals ### 2781295###Moderator###US Lead and Senior Medical Director###Pain Program at Vertex Pharmaceuticals###
Moderator: Jai Mehta, MD, MBA, FASA – Pain Program at Vertex Pharmaceuticals
### PDM-03